Article ID Journal Published Year Pages File Type
10103782 Journal of the American College of Surgeons 2005 10 Pages PDF
Abstract
LVI is an adverse prognostic factor for relapse and survival in node-negative patients treated with mastectomy and systemic therapy. LVI, in combination with age older than 50 years, premenopausal status, grade III histology, or estrogen receptor-negative disease, identified patient subsets with 7-year LRR risks of approximately 15% to 20%. Prospective research is required to define the role of adjuvant radiotherapy in these patients.
Related Topics
Health Sciences Medicine and Dentistry Surgery
Authors
, , , , , , , , ,